Index NDX, S&P 500
P/E 66.12
EPS (ttm) 5.54
Insider Own 0.68%
Shs Outstand 352.30M
Perf Week -4.80%
Market Cap 129.85B
Forward P/E 49.93
EPS next Y 7.34
Insider Trans -11.60%
Shs Float 352.02M
Perf Month -6.16%
Income 1.99B
PEG 5.35
EPS next Q 1.54
Inst Own 85.40%
Short Float 0.97%
Perf Quarter -2.26%
Sales 7.32B
P/S 17.74
EPS this Y 9.73%
Inst Trans -0.44%
Short Ratio 2.12
Perf Half Y 32.96%
Book/sh 37.77
P/B 9.70
EPS next Y 17.11%
ROA 13.76%
Short Interest 3.41M
Perf Year 22.70%
Cash/sh 20.66
P/C 17.73
EPS next 5Y 12.36%
ROE 15.73%
52W Range 254.85 - 403.76
Perf YTD 8.59%
Dividend Est. -
P/FCF 222.00
EPS past 5Y 9.71%
ROI 14.86%
52W High -9.27%
Beta 1.39
Dividend TTM -
Quick Ratio 4.02
Sales past 5Y 14.41%
Gross Margin 70.78%
52W Low 43.75%
ATR (14) 10.10
Dividend Ex-Date -
Current Ratio 4.76
EPS Y/Y TTM 52.08%
Oper. Margin 25.26%
RSI (14) 34.60
Volatility 3.65% 2.36%
Employees 13676
Debt/Eq 0.01
Sales Y/Y TTM 13.81%
Profit Margin 27.16%
Recom 2.00
Target Price 421.55
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 51.30%
Payout 0.00%
Rel Volume 2.47
Prev Close 372.63
Sales Surprise 1.09%
EPS Surprise 5.89%
Sales Q/Q 11.46%
Earnings Apr 18 AMC
Avg Volume 1.61M
Price 366.34
SMA20 -5.44%
SMA50 -5.41%
SMA200 10.11%
Trades
Volume 3,966,492
Change -1.69%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-17-23 Initiated
HSBC Securities
Buy
$318
Jul-19-23 Initiated
Robert W. Baird
Outperform
$377
Apr-19-23 Reiterated
Wells Fargo
Overweight
$289 → $310
Apr-19-23 Reiterated
Truist
Buy
$300 → $325
Apr-19-23 Reiterated
Stifel
Buy
$285 → $315
Apr-19-23 Reiterated
RBC Capital Mkts
Outperform
$305 → $309
Apr-19-23 Reiterated
Raymond James
Outperform
$270 → $323
Apr-19-23 Reiterated
Morgan Stanley
Equal-Weight
$265 → $285
Apr-19-23 Reiterated
JP Morgan
Overweight
$250 → $335
Apr-19-23 Reiterated
Evercore ISI
In-line
$240 → $270
Apr-19-23 Reiterated
Citigroup
Buy
$305 → $317
Apr-19-23 Reiterated
BTIG Research
Buy
$284 → $313
Apr-19-23 Reiterated
BofA Securities
Buy
$300 → $315
Mar-29-23 Initiated
UBS
Neutral
$278
Mar-23-23 Initiated
William Blair
Outperform
Oct-18-22 Initiated
Barclays
Overweight
$235
Oct-13-22 Initiated
Mizuho
Neutral
$215
Oct-12-22 Initiated
Jefferies
Hold
$210
Apr-13-22 Initiated
Truist
Buy
$360
Apr-06-22 Initiated
Wolfe Research
Peer Perform
$315
Show Previous Ratings
Today 01:03AM
Apr-19-24 04:13PM
(Investor's Business Daily)
10:55AM
10:08AM
(Investor's Business Daily)
08:15AM
07:59AM
Loading…
07:59AM
07:00AM
(Thomson Reuters StreetEvents)
07:00AM
03:08AM
Apr-18-24 09:46PM
09:15PM
08:53PM
06:00PM
05:15PM
04:53PM
(Investor's Business Daily)
04:52PM
Loading…
04:52PM
04:17PM
(Investor's Business Daily)
04:05PM
Apr-17-24 05:00PM
08:32AM
Apr-16-24 02:04PM
09:30AM
Apr-15-24 09:19AM
Apr-14-24 09:30AM
Apr-12-24 06:30AM
Apr-11-24 02:55PM
10:00AM
Apr-10-24 05:30PM
09:21AM
09:00AM
04:35AM
Loading…
04:35AM
Apr-09-24 06:00PM
Apr-04-24 10:52AM
10:30AM
Apr-03-24 06:00PM
Apr-02-24 07:45AM
(Investor's Business Daily)
07:04AM
Apr-01-24 02:37PM
12:10PM
06:22AM
04:30AM
Mar-31-24 07:45AM
Mar-30-24 07:18AM
Mar-29-24 09:00AM
Mar-28-24 02:36PM
08:00AM
Mar-27-24 05:50PM
Mar-26-24 10:42AM
09:30AM
Mar-25-24 06:00PM
09:53AM
Mar-22-24 02:59PM
09:46AM
Mar-21-24 08:45AM
05:06AM
Mar-20-24 09:15AM
Mar-19-24 05:50PM
02:24PM
Mar-18-24 04:30PM
09:00AM
05:42AM
Mar-15-24 04:11PM
(Investor's Business Daily)
12:17PM
(Associated Press Finance)
10:42AM
(Investor's Business Daily)
10:09AM
09:41AM
Mar-14-24 05:16PM
(Investor's Business Daily)
04:30PM
09:39AM
Mar-13-24 05:50PM
Mar-12-24 03:00PM
Mar-09-24 02:11PM
08:03AM
Mar-06-24 01:31PM
11:56AM
09:00AM
07:11AM
Mar-05-24 06:05PM
Mar-04-24 05:50PM
Mar-03-24 10:15AM
Mar-02-24 12:42AM
Feb-29-24 04:08PM
Feb-27-24 05:50PM
Feb-26-24 04:54PM
01:43AM
Feb-25-24 02:10PM
08:35AM
Feb-23-24 09:30AM
09:00AM
Feb-22-24 11:30AM
06:45AM
Feb-21-24 05:50PM
04:40PM
09:12AM
Feb-19-24 11:28AM
Feb-18-24 04:33PM
Feb-17-24 01:29PM
11:49AM
10:00AM
Feb-16-24 06:00AM
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Widman Fredrik VP Corporate Controller Mar 15 '24 Option Exercise 59.23 1,224 72,495 722 Mar 18 02:35 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Sale 397.07 5,041 2,001,630 110 Mar 18 02:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Option Exercise 243.03 329 79,956 5,627 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Sale 390.16 329 128,363 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 11 '24 Sale 390.16 196 76,471 1,058 Mar 11 04:43 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Option Exercise 297.63 14,728 4,383,438 18,224 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Sale 393.80 20,296 7,992,510 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 08 '24 Sale 392.02 196 76,836 1,254 Mar 11 04:43 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 07 '24 Sale 393.30 196 77,087 1,450 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 06 '24 Sale 386.76 196 75,805 1,646 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 05 '24 Sale 400.00 196 78,400 1,842 Mar 07 05:17 PM Curet Myriam EVP & Chief Medical Officer Mar 01 '24 Sale 383.48 1,605 615,485 298 Mar 01 06:11 PM Curet Myriam EVP & Chief Medical Officer Feb 29 '24 Option Exercise 0.00 3,256 0 3,045 Feb 29 05:00 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 29 '24 Option Exercise 0.00 3,676 0 11,772 Feb 29 05:16 PM Rosa David J. President Feb 29 '24 Option Exercise 0.00 3,757 0 218,555 Feb 29 01:18 PM Widman Fredrik VP Corporate Controller Feb 29 '24 Option Exercise 0.00 1,317 0 4,094 Feb 29 01:04 PM Samath Jamie Chief Financial Officer Feb 29 '24 Option Exercise 0.00 2,006 0 9,139 Feb 29 07:48 PM GUTHART GARY S CEO Feb 29 '24 Option Exercise 0.00 6,370 0 16,629 Mar 01 01:01 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 29 '24 Option Exercise 0.00 1,843 0 2,483 Feb 29 07:38 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 29 '24 Option Exercise 0.00 2,201 0 23,824 Feb 29 06:56 PM Miller Brian Edward EVP & Chief Digital Officer Feb 29 '24 Option Exercise 0.00 2,817 0 13,028 Feb 29 07:26 PM MOHR MARSHALL Executive VP Global Business S Feb 29 '24 Option Exercise 0.00 3,256 0 50,150 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Option Exercise 142.35 129,810 18,478,437 58,397 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Sale 385.08 108,790 41,893,066 26,877 Feb 29 07:17 PM Curet Myriam EVP & Chief Medical Officer Feb 27 '24 Sale 386.46 843 325,786 298 Feb 27 03:58 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 26 '24 Option Exercise 0.00 1,587 0 9,597 Feb 27 06:34 PM GUTHART GARY S CEO Feb 26 '24 Option Exercise 0.00 3,030 0 13,754 Feb 26 07:38 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 26 '24 Option Exercise 0.00 855 0 1,564 Feb 27 04:16 PM Curet Myriam EVP & Chief Medical Officer Feb 26 '24 Option Exercise 0.00 1,710 0 2,008 Feb 27 03:58 PM Miller Brian Edward EVP & Chief Digital Officer Feb 26 '24 Option Exercise 0.00 1,650 0 11,432 Feb 27 03:49 PM MOHR MARSHALL Executive VP Global Business S Feb 26 '24 Option Exercise 0.00 1,710 0 27,744 Feb 27 03:35 PM Rosa David J. President Feb 26 '24 Option Exercise 0.00 1,710 0 216,807 Feb 27 03:19 PM Samath Jamie Chief Financial Officer Feb 26 '24 Option Exercise 0.00 1,284 0 8,197 Feb 27 03:26 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 26 '24 Option Exercise 0.00 1,284 0 22,649 Feb 26 01:35 PM Widman Fredrik VP Corporate Controller Feb 26 '24 Option Exercise 0.00 609 0 3,298 Feb 27 01:19 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 16 '24 Sale 378.29 32 12,105 709 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 15 '24 Sale 382.03 30 11,461 741 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 14 '24 Sale 380.09 30 11,403 771 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 13 '24 Sale 375.50 30 11,265 801 Feb 13 06:27 PM Curet Myriam EVP & Chief Medical Officer Feb 12 '24 Sale 386.09 481 185,709 298 Feb 13 12:29 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 12 '24 Sale 386.09 30 11,583 831 Feb 13 06:27 PM Curet Myriam EVP & Chief Medical Officer Feb 10 '24 Option Exercise 0.00 838 0 1,136 Feb 13 12:29 PM Widman Fredrik VP Corporate Controller Feb 10 '24 Option Exercise 0.00 568 0 2,911 Feb 12 02:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 10 '24 Option Exercise 0.00 958 0 8,326 Feb 12 02:04 PM GUTHART GARY S CEO Feb 10 '24 Option Exercise 0.00 2,634 0 12,059 Feb 12 03:38 PM Samath Jamie Chief Financial Officer Feb 10 '24 Option Exercise 0.00 1,078 0 7,314 Feb 12 03:29 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 10 '24 Option Exercise 0.00 1,078 0 21,703 Feb 12 01:55 PM MOHR MARSHALL Executive VP Global Business S Feb 10 '24 Option Exercise 0.00 2,873 0 27,119 Feb 12 03:21 PM Miller Brian Edward EVP & Chief Digital Officer Feb 10 '24 Option Exercise 0.00 1,317 0 10,269 Feb 12 04:23 PM Brosius Mark See Remarks Feb 10 '24 Option Exercise 0.00 838 0 1,286 Feb 12 04:23 PM Rosa David J. President Feb 10 '24 Option Exercise 0.00 1,437 0 215,826 Feb 12 04:54 PM LOEB GARY General Counsel Feb 10 '24 Option Exercise 0.00 315 0 2,024 Feb 12 08:57 PM Rosa David J. President Feb 07 '24 Option Exercise 52.37 140,850 7,375,967 230,089 Feb 08 02:06 PM Rosa David J. President Feb 07 '24 Sale 389.28 80,710 31,418,468 163,399 Feb 08 02:06 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 01 '24 Sale 378.41 39 14,758 448 Feb 05 05:15 PM GUTHART GARY S CEO Jan 29 '24 Option Exercise 51.02 33,750 1,721,776 33,750 Jan 30 04:28 PM GUTHART GARY S CEO Jan 29 '24 Sale 376.06 24,325 9,147,669 9,425 Jan 30 04:28 PM GUTHART GARY S CEO Jan 29 '24 Sale 374.41 4,960 1,857,074 27,360 Jan 30 04:28 PM Curet Myriam EVP & Chief Medical Officer Jan 26 '24 Option Exercise 179.67 4,318 775,816 3,007 Jan 29 05:32 PM Johnson Amal M Director Jan 26 '24 Option Exercise 56.97 6,696 381,501 18,402 Jan 29 05:25 PM LEVY ALAN J Director Jan 26 '24 Option Exercise 92.79 2,000 185,578 27,247 Jan 29 05:28 PM Johnson Amal M Director Jan 26 '24 Sale 370.08 6,696 2,478,032 11,706 Jan 29 05:25 PM Curet Myriam EVP & Chief Medical Officer Jan 26 '24 Sale 370.15 4,318 1,598,298 189 Jan 29 05:32 PM LEVY ALAN J Director Jan 26 '24 Sale 370.20 2,000 740,405 25,319 Jan 29 05:28 PM Curet Myriam EVP & Chief Medical Officer Nov 16 '23 Option Exercise 173.01 8,819 1,525,799 4,689 Nov 17 03:00 PM Johnson Amal M Director Nov 16 '23 Option Exercise 41.26 9,567 394,713 21,273 Nov 17 03:11 PM Johnson Amal M Director Nov 16 '23 Sale 300.00 9,567 2,870,100 11,706 Nov 17 03:11 PM Curet Myriam EVP & Chief Medical Officer Nov 16 '23 Sale 300.00 8,819 2,645,700 189 Nov 17 03:00 PM DeSantis Robert EVP & Chief Strategy & Corp Op Nov 14 '23 Option Exercise 244.58 867 212,054 7,856 Nov 15 06:45 PM LEVY ALAN J Director Nov 14 '23 Option Exercise 90.49 2,000 180,989 27,319 Nov 15 06:44 PM LEVY ALAN J Director Nov 14 '23 Sale 290.00 2,000 580,000 25,319 Nov 15 06:44 PM DeSantis Robert EVP & Chief Strategy & Corp Op Nov 14 '23 Sale 290.00 867 251,430 7,259 Nov 15 06:45 PM GUTHART GARY S CEO Oct 26 '23 Option Exercise 49.34 33,750 1,665,336 50,936 Oct 26 07:51 PM GUTHART GARY S CEO Oct 26 '23 Sale 260.11 27,385 7,123,030 23,551 Oct 26 07:51 PM DeSantis Robert EVP & Chief Strategy & Corp Op Oct 24 '23 Option Exercise 194.12 1,110 215,468 7,823 Oct 25 04:30 PM GUTHART GARY S CEO Oct 24 '23 Sale 271.93 4,960 1,348,773 29,840 Oct 26 07:51 PM DeSantis Robert EVP & Chief Strategy & Corp Op Oct 24 '23 Sale 273.49 1,110 303,574 7,259 Oct 25 04:30 PM LOEB GARY General Counsel Oct 10 '23 Option Exercise 0.00 2,613 0 2,613 Oct 12 05:18 PM Ladd Amy L Director Sep 14 '23 Sale 305.68 500 152,840 702 Sep 15 04:39 PM LEVY ALAN J Director Aug 07 '23 Option Exercise 86.04 2,000 172,074 26,854 Aug 08 05:21 PM LEVY ALAN J Director Aug 07 '23 Sale 310.00 2,000 620,000 25,319 Aug 08 05:21 PM GUTHART GARY S CEO Jul 31 '23 Sale 325.89 4,960 1,616,414 32,320 Aug 01 04:47 PM GUTHART GARY S CEO Jul 28 '23 Option Exercise 42.64 67,500 2,877,977 67,500 Aug 01 04:47 PM GUTHART GARY S CEO Jul 28 '23 Sale 326.76 50,314 16,440,733 17,186 Aug 01 04:47 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 25 '23 Option Exercise 232.81 2,535 590,185 7,853 Jul 26 05:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 25 '23 Sale 323.26 2,535 819,460 7,259 Jul 26 05:35 PM DeSantis Robert EVP & Chief Product Officer Jun 14 '23 Option Exercise 290.33 2,443 709,276 9,702 Jun 15 05:04 PM MOHR MARSHALL Executive VP Global Business S Jun 14 '23 Option Exercise 59.46 11,250 668,950 35,386 Jun 15 05:29 PM BARRATT CRAIG H Director Jun 14 '23 Option Exercise 41.26 1,567 64,651 1,567 Jun 15 05:16 PM MOHR MARSHALL Executive VP Global Business S Jun 14 '23 Sale 325.00 11,250 3,656,250 24,136 Jun 15 05:29 PM DeSantis Robert EVP & Chief Product Officer Jun 14 '23 Sale 325.00 2,443 793,975 7,259 Jun 15 05:04 PM BARRATT CRAIG H Director Jun 14 '23 Sale 322.78 1,567 505,796 0 Jun 15 05:16 PM DeSantis Robert EVP & Chief Product Officer May 11 '23 Option Exercise 0.00 363 0 7,428 May 12 05:23 PM BARRATT CRAIG H Director May 01 '23 Option Exercise 41.26 2,000 82,516 2,000 May 02 05:15 PM BARRATT CRAIG H Director May 01 '23 Sale 306.00 2,000 612,000 0 May 02 05:15 PM RUBASH MARK J Director Apr 28 '23 Option Exercise 187.36 7,323 1,372,015 17,153 May 01 04:59 PM RUBASH MARK J Director Apr 28 '23 Sale 300.00 7,323 2,196,900 15,482 May 01 04:59 PM Beery Joseph C Director Apr 27 '23 Option Exercise 0.00 482 0 1,802 Apr 28 05:40 PM Johnson Amal M Director Apr 27 '23 Option Exercise 0.00 482 0 11,706 Apr 28 05:05 PM BARRATT CRAIG H Director Apr 27 '23 Option Exercise 0.00 655 0 25,351 Apr 28 05:33 PM
Index RUT
P/E -
EPS (ttm) -0.21
Insider Own 5.14%
Shs Outstand 181.25M
Perf Week -4.00%
Market Cap 304.55M
Forward P/E -
EPS next Y -0.05
Insider Trans -3.72%
Shs Float 171.96M
Perf Month -14.72%
Income -37.49M
PEG -
EPS next Q -0.05
Inst Own 74.62%
Short Float 3.42%
Perf Quarter -4.55%
Sales 156.37M
P/S 1.95
EPS this Y 47.30%
Inst Trans -0.34%
Short Ratio 3.61
Perf Half Y 30.23%
Book/sh 0.29
P/B 5.78
EPS next Y 55.00%
ROA -18.03%
Short Interest 5.88M
Perf Year -34.63%
Cash/sh 0.36
P/C 4.62
EPS next 5Y -
ROE -62.35%
52W Range 1.21 - 3.08
Perf YTD -22.22%
Dividend Est. -
P/FCF -
EPS past 5Y 13.81%
ROI -29.71%
52W High -45.45%
Beta 1.31
Dividend TTM -
Quick Ratio 1.55
Sales past 5Y 16.80%
Gross Margin 54.84%
52W Low 39.42%
ATR (14) 0.13
Dividend Ex-Date -
Current Ratio 2.14
EPS Y/Y TTM 13.94%
Oper. Margin -36.30%
RSI (14) 39.73
Volatility 5.91% 6.82%
Employees 288
Debt/Eq 1.82
Sales Y/Y TTM -3.51%
Profit Margin -23.98%
Recom 1.67
Target Price 4.30
Option/Short Yes / Yes
LT Debt/Eq 1.40
EPS Q/Q 90.49%
Payout -
Rel Volume 0.60
Prev Close 1.64
Sales Surprise -0.42%
EPS Surprise 63.64%
Sales Q/Q 6.21%
Earnings May 02 AMC
Avg Volume 1.63M
Price 1.68
SMA20 -6.12%
SMA50 -17.31%
SMA200 -11.92%
Trades
Volume 979,259
Change 2.44%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-12-24 Initiated
Craig Hallum
Buy
$5
Jan-20-23 Downgrade
BTIG Research
Buy → Neutral
Jan-17-23 Downgrade
Stephens
Overweight → Equal-Weight
$3.75
Oct-08-20 Resumed
BTIG Research
Buy
$9
Jun-16-20 Resumed
Cantor Fitzgerald
Overweight
$9
Feb-26-20 Initiated
BTIG Research
Buy
$7
Nov-13-19 Upgrade
BTIG Research
Neutral → Buy
$7
Aug-28-19 Initiated
Stifel
Buy
Aug-23-19 Resumed
Stephens
Overweight
Jan-05-18 Resumed
Cantor Fitzgerald
Overweight
Dec-08-17 Resumed
BTIG Research
Neutral
Jul-07-16 Resumed
Cantor Fitzgerald
Buy
$9
Dec-17-15 Downgrade
Wedbush
Outperform → Neutral
May-02-14 Reiterated
MLV & Co
Buy
$8.50 → $6
Apr-24-13 Reiterated
Cantor Fitzgerald
Buy
$5.50 → $6
Mar-15-13 Reiterated
MLV & Co
Buy
$7.50 → $8.50
Apr-17-12 Initiated
Cantor Fitzgerald
Buy
$5.50
Feb-29-12 Upgrade
Robert W. Baird
Neutral → Outperform
$3 → $6
Nov-10-11 Reiterated
MLV & Co
Buy
$4 → $5
Jun-03-11 Initiated
Wedbush
Outperform
$4
Show Previous Ratings
Apr-18-24 08:30AM
Mar-26-24 08:30AM
Mar-19-24 08:00AM
Mar-15-24 01:49AM
01:48AM
01:40PM
Loading…
Mar-07-24 01:40PM
11:46AM
Mar-06-24 06:23AM
(Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM
04:26PM
(Associated Press Finance)
04:00PM
Feb-23-24 11:56AM
Feb-20-24 08:30AM
Feb-01-24 08:30AM
Jan-15-24 09:30AM
08:30AM
Loading…
Jan-08-24 08:30AM
Nov-03-23 09:19AM
08:30AM
Nov-02-23 06:43PM
05:25PM
04:20PM
(Associated Press Finance)
04:00PM
Oct-19-23 08:30AM
Oct-10-23 08:30AM
Sep-27-23 08:30AM
Sep-12-23 08:30AM
Aug-02-23 05:15PM
04:11PM
(Associated Press Finance)
04:00PM
Jul-31-23 12:36PM
08:30AM
Loading…
Jul-19-23 08:30AM
Jul-03-23 05:13PM
Jun-15-23 08:30AM
Jun-14-23 08:30AM
Jun-07-23 10:30AM
Jun-05-23 08:30AM
May-30-23 07:16AM
May-04-23 05:15PM
04:10PM
04:00PM
May-02-23 12:25PM
Apr-20-23 08:30AM
Apr-18-23 10:54AM
Mar-10-23 09:24AM
Mar-09-23 11:45AM
Feb-28-23 04:00PM
Feb-21-23 11:00AM
Feb-15-23 08:30AM
Feb-10-23 08:30AM
Jan-19-23 11:45AM
Jan-09-23 08:30AM
Dec-21-22 05:50AM
Nov-09-22 05:58AM
Nov-04-22 08:00AM
Nov-03-22 05:55PM
04:00PM
Nov-02-22 01:52PM
Nov-01-22 08:00AM
Oct-20-22 08:30AM
Sep-26-22 08:00AM
Sep-21-22 09:35AM
Sep-14-22 11:55AM
Sep-13-22 11:17AM
Aug-29-22 09:35AM
Aug-24-22 07:58AM
Aug-12-22 08:00AM
Aug-05-22 01:00PM
Aug-04-22 05:25PM
04:00PM
Jul-28-22 09:48AM
Jul-21-22 08:00AM
Jul-14-22 12:00PM
06:25AM
Jul-13-22 11:37AM
Jul-05-22 05:00PM
Jun-23-22 09:55AM
Jun-14-22 08:00AM
Jun-03-22 09:55AM
May-17-22 05:00AM
May-16-22 09:55AM
May-15-22 08:42AM
May-06-22 02:30AM
May-05-22 05:15PM
04:00PM
May-03-22 08:00AM
Apr-28-22 08:35AM
Apr-25-22 08:00AM
Apr-21-22 08:00AM
Apr-07-22 11:39AM
Feb-25-22 08:00AM
Feb-23-22 10:00AM
Feb-22-22 10:00PM
04:01PM
Feb-08-22 08:00AM
Feb-07-22 04:05PM
Feb-04-22 05:36AM
Jan-28-22 01:38PM
Jan-10-22 08:00AM
Dec-28-21 10:00AM
Dec-06-21 04:43AM
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Greenman William Mariner President and CEO Mar 14 '24 Sale 2.02 63,611 128,195 3,181,281 Mar 14 09:30 PM Jayaraman Vivek K Chief Operating Officer Mar 14 '24 Sale 1.97 26,794 52,902 878,653 Mar 14 09:33 PM Green Kevin Dennis Chief Financial Officer Mar 14 '24 Sale 1.97 21,497 42,444 618,750 Mar 14 09:53 PM Jensen Chrystal Chief Legal Officer Mar 14 '24 Sale 1.97 17,824 35,192 490,912 Mar 14 09:47 PM Benjamin Richard J Chief Medical Officer Mar 14 '24 Sale 1.97 17,738 35,022 459,612 Mar 14 09:15 PM CORASH LAURENCE M Chief Scientific Officer Mar 14 '24 Sale 1.97 14,360 28,352 2,339,740 Mar 14 09:22 PM Greenman William Mariner President and CEO Mar 13 '24 Sale 2.06 62,315 128,182 3,244,892 Mar 14 09:30 PM Jayaraman Vivek K Chief Operating Officer Mar 13 '24 Sale 2.06 26,247 53,990 905,447 Mar 14 09:33 PM Green Kevin Dennis Chief Financial Officer Mar 13 '24 Sale 2.02 21,058 42,438 640,247 Mar 14 09:53 PM Moore Carol SVP Reg. & Quality Mar 13 '24 Sale 2.02 20,619 41,553 490,623 Mar 14 09:49 PM Jensen Chrystal Chief Legal Officer Mar 13 '24 Sale 2.06 17,460 35,915 508,736 Mar 14 09:47 PM Benjamin Richard J Chief Medical Officer Mar 13 '24 Sale 2.06 17,377 35,744 477,350 Mar 14 09:15 PM CORASH LAURENCE M Chief Scientific Officer Mar 13 '24 Sale 2.06 14,067 28,936 2,354,100 Mar 14 09:22 PM Benjamin Richard J Chief Medical Officer Mar 08 '24 Sale 2.40 29,378 70,457 478,061 Mar 12 06:10 PM BJERKHOLT ERIC Director Dec 13 '23 Buy 1.62 10,000 16,200 142,133 Dec 13 05:55 PM Lucena Ann Director Aug 22 '23 Buy 1.69 7,500 12,638 72,284 Aug 23 06:11 PM BJERKHOLT ERIC Director Aug 21 '23 Buy 1.72 10,000 17,151 132,133 Aug 23 06:08 PM Swisher Daniel N JR Director May 26 '23 Buy 1.91 5,000 9,535 118,808 May 30 03:45 PM SCHULZE GAIL Director May 24 '23 Buy 2.03 9,850 19,981 83,420 May 24 07:18 PM BJERKHOLT ERIC Director May 23 '23 Buy 2.00 5,000 10,000 82,133 May 23 05:57 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite